Alzheimer's drugs improve perception

05/2013

Most of the (few) approved Alzheimer’s drugs are cholinesterase inhibitors — that is, they stop the breakdown of the neurotransmitter acetylcholine. A new study explains why they help. It appears they allow signals to enter the brain with more precision and less background noise.

The study involved 13 healthy young adults, some of whom were given the cholinesterase inhibitor galantamine, before listening to a series of modulating tones while focusing on a simple concentration task. The patterns of neural activity demonstrated by those on the drug most closely fit a model in which the signals coming into the brain were sharpened. This was something of a surprise, since it has been generally assumed that the effects would be most pronounced in the ‘higher-order’ processing regions.

The findings are an interesting reminder of the importance of sensory perception for optimal cognition. It should be noted, though, that this sharpening of the signal did occur in an environment in which the stimuli were predictable.

http://www.eurekalert.org/pub_releases/2013-05/vt-taf050713.php

[3407] Moran, R. J., Campo P., Symmonds M., Stephan K. E., Dolan R. J., & Friston K. J.
(2013).  Free Energy, Precision and Learning: The Role of Cholinergic Neuromodulation.
The Journal of Neuroscience. 33(19), 8227 - 8236.

Related News

Research into the link, if any, between cholesterol and dementia, has been somewhat contradictory. A very long-running Swedish study may explain why.

A study involving 360 patients with degenerative dementia (109 people with dementia with

In a study in which 78 healthy elders were given 5 different tests and then tested for cognitive performance 18 months later, two tests combined to correctly predict nearly 80% of those who developed significant cognitive decline.

A study involving 676 children (7-9) in rural Nepal has found that those whose mothers received iron, folic acid and vitamin A supplementation during their pregnancies and for three months after the birth performed better on some measures of intellectual and motor functioning compared to offspri

Clinical records of 211 patients diagnosed with probable Alzheimer's disease have revealed that those who have spoken two or more languages consistently over many years experienced a delay in the onset of their symptoms by as much as five years.

A study involving 68 healthy older adults (65-85) has compared brain activity among four groups, determined whether or not they carry the Alzheimer’s gene ApoE4 and whether their physical activity is reported to be high or low.

Following on from previous studies showing that drinking beet juice can lower blood pressure, a study involving 14 older adults (average age 75) has found that after two days of eating a high-nitrate breakfast, which included 16 ounces of beet juice, blood flow to the

A six-year study involving over 1200 older women (70+) has found that low amounts of albumin in the urine, at levels not traditionally considered clinically significant, strongly predict faster cognitive decline in older women.

More evidence that vascular disease plays a crucial role in age-related cognitive impairment and Alzheimer’s comes from data from participants in the Alzheimer's Disease Neuroimaging Initiative.

A simple new cognitive assessment tool with only 16 items appears potentially useful for identifying problems in thinking, learning and memory among older adults.

Pages

Subscribe to Latest newsSubscribe to Latest newsSubscribe to Latest health newsSubscribe to Latest news
Error | About memory

Error

The website encountered an unexpected error. Please try again later.